HANOI (Reuters) -Sanofi and Vietnam Vaccine JSC, or VNVC, on Tuesday launched a vaccine manufacturing facility in Vietnam, aimed at producing vaccines for domestic use and export.
The launch was witnessed by French President Emmanuel Macron during his visit to the Southeast Asian country.
The plant, situated in the southern province of Long An, spans 2.6 hectares (6.4 acres) and has received an initial investment of 2 trillion dong ($77.19 million), VNVC said in a statement in response to a query from Reuters.
The facility is projected to produce 100 million doses annually, with operations expected to begin by the end of 2027.
VNVC did not clarify which vaccines would be produced at the facility.
On Monday, Sanofi and VNVC also signed an agreement on technology transfer.
($1 = 25,911.0000 dong)
(Reporting by Phuong Nguyen; Editing by Martin Petty)
Comments